Selection of a phage-displayed peptide recognized by monoclonal antibody directed blocking the site of hepatitis C virus E2 for human CD81

Journal of Microbiological Methods

Volumn 68, Issue 3, 2007, Pages 601-604

  Cao, J ^a   Liao, X L ^a   Wu, S M ^b   Zhao, P ^a   Zhao, L J ^a   Wu, W B ^a   Qi, Z T ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Anti human CD81 monoclonal antibody; Hepatitis C virus envelope glycoprotein 2; Phage peptide library; Small peptide

Indexed keywords

ALANYLTHREONYLTRYPTOPHYLVALYLCYSTEINYLGLYCYLPROLYLCYSTEINYLTHREONINE; ANTIVIRUS AGENT; CD81 ANTIGEN; GLYCOPROTEIN E2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY JS 81; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BINDING SITE; DRUG TARGETING; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS C VIRUS; HOST CELL; NONHUMAN; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIGENS, CD; BINDING SITES; ENZYME-LINKED IMMUNOSORBENT ASSAY; HEPACIVIRUS; HUMANS; MOLECULAR SEQUENCE DATA; PEPTIDE LIBRARY; PEPTIDES; VIRAL ENVELOPE PROTEINS;

HEPATITIS C VIRUS;

EID: 33847331971     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2006.11.009     Document Type: Article

References (28)

1. Adda C.G., Anders R.F., Tilley L., and Foley M. Random sequence libraries displayed on phage: identification of biologically important molecules. Comb. Chem. High Throughput Screen. 5 1 (2002) 1-14
2. Barnes E., Harcourt G., Brown D., Lucas M., Phillips R., Dusheiko G., and Klenerman P. The dynamics of T-lymphocyte responses during combination therapy for chronic hepatitis C virus infection. Hepatology 36 3 (2002) 743-754
3. Bartenschlager R., and Lohmann V. Replication of hepatitis C virus. J. Gen. Virol. 81 (2000) 1631-1648
4. Barth H., Schafer C., Adah M.I., Zhang F., Linhardt R.J., Toyoda H., Kinoshita-Toyoda A., Toida T., Van Kuppevelt T.H., Depla E., Von Weizsacker F., Blum H.E., and Baumert T.F. Cellular binding of hepatitis C virus envelope glycoprotein E2 requires cell surface heparan sulfate. J. Biol. Chem. 278 42 (2003) 41003-41012
5. Bartosch B., Vitelli A., Granier C., Goujon C., Dubuisson J., Pascale S., Scarselli E., Cortese R., Nicosia A., and Cosset F.L. Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J. Biol. Chem. 278 43 (2003) 41624-41630
6. Cao J., Zhao P., Miao X.H., Zhao L.J., Xue L.J., and Qi Z.T. Phage display selection on whole cells yields a small peptide specific for HCV receptor human CD81. Cell Res. 13 6 (2003) 473-479
7. Cohen J. The scientific challenge of hepatitis C. Science 285 (1999) 26-30
8. Cooper S., Erickson A.L., Adams E., Kansopon J., Weiner A.J., Chien D.Y., Houghton M., Parham P., and Walker C.M. Analysis of a successful immune response against hepatitis C virus. Immunity 10 (1999) 439-449
9. Cormier E.G., Tsamis F., Kajumo F., Durso R.J., Gardner J.P., and Dragic T. CD81 is an entry coreceptor for hepatitis C virus. Biochemistry 101 19 (2004) 7270-7274
10. Ferrer M., and Harrison S.C. Peptide ligands to human immunodeficiency virus type 1 gp120 identified from phage display libraries. J. Virol. 73 7 (1999) 5795-5802
11. Flint M., Maidens C., Loomis-price L.D., Shotton C., Dubuisson J., Monk P., Higginbottom A., Levy S., and Mckeating J.A. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol. 73 (1999) 6235-6244
12. Flint M., Dubuisson J., Maidens C., Harrop R., Guile G.R., Borrow P., and McKeating J.A. Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein. J. Virol. 4 (2000) 702-709
13. Gardner J.P., Durso R.J., Arrigale R.R., Donovan G.P., Maddon P.J., Dragic T., and Olson W.C. L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus. Proc. Natl. Acad. Sci. U. S. A. 100 8 (2003) 4498-4503
14. Kato N., Hijikta M., Ootsuyma Y., Nakagawa M., Ohkoshi S., Sugimura T., and Shimotono K. Molecular cloning of the human hepatitis C virus genome from Japanese patients with non-A, non-B hepatitis. Proc. Natl. Acad. Sci. U. S. A. 87 24 (1990) 9524-9528
15. Lindenbach B.D., Evans M.J., Syder A.J., Wölk B., Tellinghuisen T.L., Liu C.C., Maruyama T., Hynes R.O., Burton D.R., McKeating J.A., and Rice C.M. Complete replication of hepatitis C virus in cell culture. Science 309 5734 (2005) 623-626
16. Marks J.D., Hoogenboom H.R., Boonet T.P., McCafferty J., Griffiths A.D., and Winter G. By-passing immunization: human antibodies from V-gene libraries displayed on phage. J. Mol. Biol. 222 (1991) 581-597
17. Monazahian M., Bohme I., Bonk S., Koch A., Scholz C., Grethe S., and Thomssen R. Low density lipoprotein receptor as a candidate receptor for hepatitis C virus. J. Med. Virol. 57 3 (1999) 223-229
18. Oren R., Takahashi S., Doss C., Levy R., and Levy S. TAPA-1, the target of an antiproliferative antibody, defines a new family of transmembrane proteins. Mol. Cell. Biol. 10 8 (1990) 4007-4015
19. Paradis-Bleau C., Sanschagrin F., and Levesque R.C. Identification of Pseudomonas aeruginosa FtsZ peptide inhibitors as a tool for development of novel antimicrobials. J. Antimicrob. Chemother. 54 1 (2004) 278-280
20. Petracca R., Falugi F., Galli G., Norais N., Rosa D., Campagnoli S., Burgio V., Stasio E.D., Giardina B., Houghton M., Abrignani S., and Grandi G. Structure-function analysis of hepatitis C virus envelope-CD81 binding. J. Virol. 74 (2000) 4824-4830
21. Piler iP., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., Weiner A.J., Houghton M., Rosa D., Grandi G., and Abrignani S. Binding of hepatitis C virus to CD81. Science 282 (1998) 938-940
22. Pohlmann S., Zhang J., Baribaud F., Chen Z., Leslie G.J., Lin G., Granelli-Piperno A., Doms R.W., Rice C.M., and McKeating J.A. Hepatitis C virus glycoproteins interact with DC-SIGN and DC-SIGNR. J. Virol. 77 7 (2003) 4070-4080
23. Prezzi C., Nuzzo M., Meola A., Delmastro P., Galfre G., Cortese R., Nicosia A., and Monaci P. Selection of antigenic and immunogenic mimics of hepatitis C virus using sera from patients. J. Immunol. 156 (1996) 4504-4513
24. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning: A Laboratory Manual. 2nd ed (1989), Cold Spring Harbor Laboratory Press, USA 16-34
25. Simon-Haldi M., Mantei N., Franke J., Voshol H., and Schachner M. Identification of a peptide mimic of the L2/HNK-1 carbohydrate epitope. J. Neurochem. 83 6 (2002) 1380-1388
26. Tachibana I., and Hemler M.E. Role of transmembrane 4 superfamily (TM4SF) proteins CD9 and CD81 in muscle cell fusion and myotube maintenance. J. Cell Biol. 146 4 (1999) 893-904
27. Triyatni M., Saunier B., Maruvada P., Davis A.R., Ulianich L., Heller T., Patel A., Kohn L.D., and Liang T.J. Interaction of hepatitis C virus-like particles and cells: a model system for studying viral binding and entry. J. Virol. 76 18 (2002) 9335-9344
28. Zhang J., Randall G., Higginbottom A., Monk P., Rice C.M., and McKeating J.A. CD81 is required for hepatitis C virus glycoprotein-mediated viral infection. J. Virol. 78 3 (2004) 1448-1455